Title : Effect of budesonide on TGF-beta1-enhanced VEGF production by lung fibroblasts.

Pub. Date : 2010 Jul

PMID : 20359293






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Effect of budesonide on TGF-beta1-enhanced VEGF production by lung fibroblasts. Budesonide vascular endothelial growth factor A Homo sapiens
2 Since the glucocorticoids have shown antifibrosis properties, we sought to investigate whether budesonide, a widely used glucocorticoid in clinical practice, could attenuate TGF-beta1 (transforming growth factor-beta1)-induced VEGF production by HFL-1 (human lung fibroblasts). Budesonide vascular endothelial growth factor A Homo sapiens
3 The results suggested that budesonide pretreatment reduced the significant increase of VEGF release induced by TGF-beta1 in HFL-1 fibroblasts in a dose-dependent manner, and suppressed the increase of phospho-Smad3 and phosphor-ERK (extracellular signal-regulated kinase) protein levels. Budesonide vascular endothelial growth factor A Homo sapiens
4 In conclusion, budesonide may reduce TGF-beta1-induced VEGF production in the lung, probably through the Smad/ERK signalling pathway and, thus, may provide new sight into the molecular mechanism underlying glucocorticoid therapy for airway inflammatory diseases. Budesonide vascular endothelial growth factor A Homo sapiens